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Abstract
Background/Aims: Chronic medical illness is a significant risk factor for the development of 
psychiatric disorders. The aims of the study were: to investigate the level of anxiety in children 
with chronic kidney disease (CKD) and to identify factors associated with the presence of that 
emotional problem. Methods: CKD children on hemodialysis (HD, n=22), peritoneal dialysis 
(PD, n=20,) and on conservative treatment (CT, n=95) were enrolled in the study. We used State-
Trait Anxiety Inventory (STAI) for adolescents and STAI-C for children. Socio-demographic and 
physical factors were assessed. Results: There was a significantly higher level of anxiety-state 
among HD children (8-12 years) compared with other groups of participants of the same age 
and Polish population norms. The level of anxiety among adolescents (13-18 years), both 
anxiety-state and anxiety-trait, was significantly higher in the HD group compared with other 
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groups, which did not differ among themselves. In the HD adolescents, there was a correlation 
between the anxiety-state and the duration of the disease as well as with the number of 
hospitalizations. PD adolescents in the mainstream education had higher levels of anxiety-
state and anxiety-trait compared with home schooled patients. Conclusions: Even though 
children and adolescents with CKD are at risk of developing a variety of emotional disorders, 
the level of anxiety among the researched group, with the exception of HD patients, was not 
significantly different than the level of anxiety among healthy subjects. Adolescents on HD 
who present a high level of anxiety should undergo long-term psychological treatment.
 Copyright © 2013 S. Karger AG, Basel
Introduction
Chronic medical illness is a significant risk factor for the development of psychiatric 
disorders, including anxiety [1, 2]. Psychiatric disorders may develop as a response to being 
ill or in the hospital, to a threatening environment, as a result of genetic and psychosocial 
factors or may be secondary to metabolic disturbances related to the specific medical illness, 
or as a combination of all these factors [3-6]. Psychiatric disorders can increase the severity 
of the preexisting physical illness by, among other ways, disturbing cardiac and nervous 
system, decreasing immune function or modulating nutritional conditions [7, 8]. They can 
also influence patient compliance [9]. It is believed that moderate to severe anxiety affects 
symptom management, treatment adherence, medical outcome, and the ability of the child/
adolescent to cope with the illness [1, 2, 7]. Anxiety, a part of emotional status, is perceived 
as one of very important aspects of health-related quality of life [10-12]. This is why anxiety 
should be spotted early and appropriately treated.
Despite the increased significance of anxiety in somatic diseases, data on its appearance 
among children with chronic kidney disease (CKD) is limited and diversified. Bakr et al., 
in their research of 38 children with CKD, noted the appearance of anxiety in 1 among 19 
patients treated with HD and in 1 patient with CKD in the pre-dialysis period [4]. However, in 
general, emotional disorders were noted among 52.6% of patients, in the majority of cases as 
adjustment disorders with depression (in 18.4%) and depressive disorders (in 10.3%). Amr 
et al. showed significantly higher results on the anxiety/depression scale of CBCL (the child 
behavior checklist) in the group of dialyzed and pre-dialyzed children than in the group of 
children without chronic diseases [13]. However, using another tool (SCICA, semi-structure 
clinical interview for children and adolescents) the authors noted, on the contrary, higher 
results in the reference group than in groups of sick patients. So far, no factors have been 
connected to the level of anxiety among CKD children. More information about anxiety 
among patients with CKD concerns mainly adults [14-18]. According to Livesley, depression 
and anxiety disorders are most commonly psychiatric comorbidity in adults with CKD [19]. 
In patients on dialysis, the prevalence rate for anxiety is about 30 to 45%. Anxiety influences 
the quality of the patient’s life and anxiety–trait was mainly related to emotional upset and 
social relationships [17, 20, 21].
Advocating for the concept that the human being is the psychosomatic unity, we 
undertook in Poland multicentre studies of psychosocial aspects of children with CKD. 
There were two aims of the present study. The first was to investigate the level of anxiety in 
children with CKD, using State-Trait Anxiety Inventory (STAI) by Spielberger [22]. It is based 
on the theory that distinguishes between state anxiety, i.e. transitory emotional condition 
and trait anxiety defined as personality trait, a disposition to perceive evaluative situation 
as threatening [23]. The second one was to identify factors associated with the presence of 
those psychiatric problems. 
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Materials and Methods
Participants
Eleven out of twelve pediatric nephrology centers in Poland participated in the cross-sectional national 
study. The research was conducted on CKD children on hemodialysis (HD, n=22), peritoneal dialysis (PD, 
n=20,) and on conservative treatment (CT, n=95). 
All children on HD and PD have end stage renal disease (ESRD). ESRD patients were included to CKD 
group based on current CKD classification (CKD stage 5 contains ESRD) [21] and for the reason of more 
convenient analysis.  
The inclusion criteria were as follows: (1) over 8 years of age, (2) stage III of CKD or higher according 
to KDOQI [24] based on the estimated glomerular filtration rate (eGFR) by the Schwartz formula [25], (3) 
CKD diagnosed at least 3 months prior to the begin of the study, and (4) informed consent. Exclusion criteria 
were: (1) history of severe to profound mental retardation, (2) renal, other solid-organ, bone marrow or 
stem cell transplantation, (3) cancer/leukaemia diagnosis, (4) hospitalization within 14 days (with the 
exception of a hospital stay for HD or PD), (5) initiation or change of dialysis modalities within the past 
30 days, (6) a significant life event unrelated to their kidney disease in the past 30 days, such as losing 
a family member, severe illness of a family member, family structure changes, changing the living place. 
The study protocol adhered to the Declaration of Helsinki and was approved by the Ethics Committee of 
Wroclaw Medical University. A written informed consent of the children and their parents was obtained 
before enrollment in the study. 
A semi-structured interview form developed by the investigators was used to determine the 
demographic characteristics of the participants, their schooling level, place of living and family structure. 
Medical files were analyzed to obtain the following data: primary diagnosis of kidney disease, patient’s age 
at the time of CKD diagnosis, duration of illness, duration of renal care, family medical history and selected 
lab test results. 
CT and PD patients were examined during their check-up appointments, but patients with HD were 
examined on the day of their hemodialysis session, just before arriving to the dialysis unit, before being 
connected to the machine. All dialysed patients were maintained on a single modality of dialysis. No patient 
switched.
Methods 
The anxiety levels of the subjects were evaluated using a Spielberger STAI or State-Trait Anxiety 
Inventory for Children (STAI-C) (Mind Garden, Inc., Menlo Park, CA), depending on the age of the patient.
The STAI has been used extensively in anxiety-related research and clinical practice as a standard 
measurement tool for assessing anxiety in adolescents (13-18 year). It contains two 20-item questionnaires 
designed to measure how subjects feel “right now, at present circumstances” (state anxiety, form X-1) and 
how much anxiety represents a personality characteristic (trait anxiety, form X-2). Answers on the state 
anxiety scale range from 1 to 4 (1 [not at all], 2 [somewhat], 3 [moderately so], 4 [very much so]). Answers 
on the trait anxiety scale range from 1 to 4 (1 [almost never], 2 [sometimes], 3[often], 4 [almost always]). 
The total score ranges from 20 to 80. These scores represent low (20-30), average (31-49) and high (≥ 50) 
levels of anxiety. The STAI has been translated and validated in Poland [26].
The STAI-C is a self-report questionnaire consisting of two 20-item subscales that evaluate the state 
and the trait anxiety in children (8-12 years). The state subscale (form C-1) examines the shorter-term 
anxiety that is commonly specific to situations. The trait subscale (form C-2) measures longer-term anxiety 
which addresses how the child generally feels. Each item is scored from 1 to 3. The higher scores indicate 
higher levels of anxiety. A validity and reliability study in the Polish pediatric population was performed by 
Sosnowski et al. [27].
The results of STAI-C and STAI in CKD patients were referred to the Polish population norms for 
children and adolescents, respectively [26, 27].
The children and adolescents answered the questionnaire (STAI-C and STAI, respectively) alone.
Statistical analysis
Statistical analyses were performed using R for Windows, version 2.15.1 (The R Foundation for 
Statistical Computing, Vienna, Austria) and MedCalc for Windows, version 12.3.1.0 (MedCalc Software, 
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Mariakerke, Belgium).  Quantitative variables were tested for normality distribution using the Kolmogorov-
Smirnov test. Medians, quartiles, mean values and standard deviations were reported to describe the data, 
as appropriate. For comparison between groups the ANOVA test, the Kruskal-Wallis and Mann-Whitney U 
tests were used, as appropriate. Additionally, post-hoc analysis with Holm-correction was made. Spearman`s 
correlation analysis was used to determine the correlation between parameters. Accuracy of correlations 
was assessed using bootstraping method with 1000 samples. A p-value of less than 0.05 was considered 
statistically significant.
Results
The characteristics of the examined children are presented in Table 1. Some patients 
have additional diseases. In group I seven children have hypertension and one boy 
hemodynamically insignificant heart defect. In group II ten adolescents have hypertension, 
four - epilepsy, one allergy and four children have liver diseases.
Some HD children in group I had blood access via catheter (group HD1)  and some via 
AV-fistula (group HD2). We performed analysis of STAI-C results in HD children depending 
on the kind of blood access (Table 2). The differences were not remarkable (p=0.95 for “state 
anxiety” and p=0.69 for “trait anxiety”). In group II all children were hemodialysed using 
AV-fistula. So, this factor (blood access for HD) wasn’t taken into account in further analysis.
There was a significantly higher level of the anxiety-state among children (8-12 years) 
treated with hemodialysis compared with other groups of sick children the same age and 
normative data (24). There were no differences concerning the level of anxiety-trait between 
the abovementioned groups (Table 2). Among adolescents, the level of anxiety-state was low 
among 26 patients (28%), average among 58 patients (62%) and high among 9 patients 
(10%). The level of anxiety-trait was low among 18 patients from this group (19.4%), 
average among 61 patients (65.6%) and high among 14 patients (15%). The level of anxiety 
among adolescents, both the anxiety-state and anxiety-trait, was significantly higher in HD 
group compared with other groups (on PD and CT) and with normative data (23), which did 
not differ among themselves (Table 3). The correlations between anxiety-state and anxiety-
trait were presented in Table 4.
In the whole group of sick children there were no significant correlations between 
the results of STAI-C scales (state, trait), STAI scales (state, trait) and such factors as: age 
of CKD diagnosis, the duration of the disease, the duration of renal care, the number of 
hospitalizations, serum creatinine, eGFR, and hemoglobin. There was no relationship 
between the level of anxiety (both state and trait) and the gender, the place of living, the 
family structure (full or incomplete, with or without siblings) or with the physical traits of 
patients, such as the body mass percentile and the height percentile. However, there were 
significant correlations in groups of children with CKD, singled out due to the modality of 
treatment. In the group of HD adolescents, there was a connection between anxiety-state and 
the duration of the disease (r=0.58, p=0.04) and, below the statistical significance, between 
the anxiety-state and the number of hospitalizations (r=0.46, p=0.09). There was a higher 
level of anxiety (both trait and state) among PD adolescents with the mainstream education 
compared with home-schooled patients (U=7.5, p=0.05 and U=8.5, p=0.07, respectively). No 
significant correlation was noted in the group of children 8-12 years.
Discussion
Anxiety disorders are one of the most common emotional disorders in the general 
population [28]. It is believed that the prevalence of anxiety disorders among children/
adolescents with different chronic medical illnesses is higher compared to their healthy 
counterpart [1-3]. The rates of anxiety symptoms in pediatric patients range from 7 to 40%, 
depending on the type of disease, examined group or used methods [2, 3]. In the examined 
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Table 1. Socio-demographic and clinical characteristics of CKD patients
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30]. Although some studies have failed to find a link between asthma and depression in 
children [31].     
Studies on emotional disorders among children with CKD are inconsistent. Some 
authors, assessing the social-behavioral functioning in children (also anxiety disorders), 
stated that they were similar to that of demographically matched peers [12, 32]. However, 
Fukunishi et al. noted the separation anxiety among as much as 65% of patients treated for 
CAPD and HD [33]. The interpretation of our results should be carried out carefully, because 
the number of the examined cohort and its diversity, depending on the manner of treatment 
and many socio-demographic traits, which cannot be avoided in clinical research. The level 
of anxiety, appropriate to the age, among the majority of patients may result from the fact 
that the disease was diagnosed in early childhood, the long duration of the disease, and 
the fact that patients had been under long-standing specialist renal care. The figures of the 
mentioned parameters (in the group of children 8-12 years, parameter medians: 2, 6, 5 years 
respectively) indicate that for most of its life, the child had been sick, thereby familiarizing 
the child with the disease which, becomes a natural state for the child. According to Soliday 
et al., depression and anxiety among patients and their next-to-kin are the strongest at the 
beginning of the disease [32]. After about 1 year following the diagnosis, the life of the family 
and the patients stabilizes. One of the concepts explaining this condition is the so-called 
adaptation to the stressor (the stressing factor) [34]. Similarly, Watnick et al., studying 
dialyzed patients, claimed that the symptoms of anxiety are most common at the beginning 
of the treatment [5].
The increased level of anxiety-state among patients on HD may be explained by the 
specificity of this renal replacement therapy. The hemodialysis sessions in themselves are 
commonly associated with acute feelings of anxiety. According to the studies by Feroze 
et al., anxiety among hemodialyzed patients was triggered when patients arrived for HD 
Table 4. The correlation coefficients between 
state anxiety and trait anxiety in group I (8-12 
years of age, STAI-C) and group II (13-18 year of 
age, STAI)
Table 2. State-Trait Anxiety Inventory for Children 
(STAI-C) comparisons of CKD and normative data
Table 3. State-Trait Anxiety Inventory (STAI) com-
parisons of CKD and normative data
cohort, the level of anxiety among the majority 
of children did not significantly differ from 
the level of anxiety among healthy children. In 
the group of children 8-12 years, we observed 
only a higher level of anxiety-state among 
children on HD, but in the group of adolescents, 
also only the ones undergoing HD, both the 
anxiety-state and anxiety-trait. This indicates 
that adaptation to the illness among patients 
with CKD is partially successful. Other authors 
indicated a significantly higher level of anxiety 
among children with such diseases as asthma, 
diabetes or epilepsy, may lead to a medical 
crisis and also make a child more anxious 
about being away from their caregivers [29, 
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treatment, when they heard alarm and machine sound or when new staff connected the 
patient to dialysis machine [17]. These observations suggest that the modification in the 
conduct of hemodialysis may reduce some anxiety during the dialysis treatment.
The adolescents on HD are the group of patients, which requires the particular treatment 
due to the high level of anxiety. Their level of anxiety-state may be not only conditioned 
by the stress connected with HD treatment, but also with the high level of anxiety-trait. 
In our studies, we have shown the positive correlation between the state and the trait of 
anxiety, which is in accordance with the Spielberger results, as well as other authors [2, 22, 
23]. Why does the anxiety as the personal trait becomes characteristic for hemodialysed 
adolescents? Adolescents 13-18 years of age may be aware of their limitations connected 
with the disease, which may result in their anxiety about the future [2, 28]. Paradoxically, the 
extended duration of disease will not make it easier for the patients to adjust to the situation, 
but it will lead to the further enhancement of anxiety [29]. This suggestion may be supported 
by our observation of the positive correlation between the time of treatment and the level of 
anxiety-state. Anxiety may be exacerbated by the social isolation arising from the necessity 
of arriving to hemodialysis sessions and from frequent hospitalizations. To a smaller extent, 
the coincidence of such adverse factors concerns adolescent patients treated with PD, who 
are not “taken” from their natural family environment (treatment at home, the possibility to 
attend school, more time for contacts with peers). In our studies, we have not noted a higher 
level of anxiety in this group of patients. We observed, however, the connection between 
the level of anxiety with the type of education. Perhaps, children treated with PD and who 
have daily contact with healthy peers at school, discern their otherness in many ways, and 
therefore they underestimate their abilities.
In our studies, we have not shown the correlation between the level of anxiety with 
many demographical and clinical factors. Bakr et al. made similar observations concerning 
psychiatric disorders, among others, anxiety [4]. There was no correlation between the 
psychiatric disorders and age, sex, the duration of CKD, the duration and efficiency of HD 
and the severity of anemia among the group of children with CKD 5-16 years (average age 
12 years).
The enhanced level of anxiety is certainly harmful and may pose a vicious circle 
comprised of mental disorders and unsatisfying compliance.  Stating the level of anxiety and 
its treatment in the case of anxiety enhancement is not only significant in this age group, 
as has been stated in reference to adolescents undergoing hemodialysis. Children requiring 
the maintenance dialysis will never fully recover. Their emotional problems may be chronic. 
It was shown that anxiety and depression are the main psychiatric disorders among adults 
treated with HD [14, 16, 18]. Cukor et al., based on the long-term observations of adults 
with such abnormalities, stated that 34% of these patients had an intermittent course and 
as much as among 15% the persistent course [20]. It was also documented that anxiety and 
depression significantly lower the quality of life and may negatively affect the course of the 
disease [21]. In addition, suffering from anxiety or depression is a predictor for elevated 
mortality in adults [15, 16].
Our studies have some limitations. As mentioned above, the studied cohort was 
diversified. We have not taken into consideration a variety of factors that may determine 
the anxiety among sick children, such as e.g. the parental adjustment. Parents, their believes, 
emotions, attitude towards patients, have a strong influence on perceiving the life situation 
by patients [35]. We were aware that the family relationships can affect also emotional 
status of children. In current study this factor was not taken into account. However, we 
could evaluate the relationships in families of examined patients as proper on the basis of 
interview with children and their parents, medical history and our observations of patients. 
No data indicated “adverse family relationship”. 
Another factor connected with the level of anxiety, which we did not examine, may be 
the so-called sense of locus of control. This term describes the degree of perceived control 
that everyone has over its environment to get about favorable consequences.  Hommel 
et al. noted the presence of increased depressive symptoms in a group of children with 
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juvenile rheumatic disease only when the child perceived little control over the situation 
[36]. Similarly, Birmele et al., assessing the health-related quality of life in adult chronic 
hemodialysis patients, stated that patients who viewed themselves as having control over 
their situation had better mental health [37]. The above observations not only suggest that 
the feeling of control may influence the level of anxiety in patients, but it can mean that 
patients should develop their inner locus.
It had been stated that anxiety is perceived as one of very important aspects of health-
related quality of life (QoL). Thus the true influence of anxiety on QoL and the relationships 
between different dimensions of QoL and anxiety should be examined in the future studies.
     
Conclusion
To conclude, even though children and adolescents with CKD are at risk of developing 
a variety of emotional disorders, the level of anxiety among the researched group, with the 
exception of patients treated with hemodialysis, was not significantly different than the level 
of anxiety among healthy children. Adolescent patients who present the high level of anxiety 
should be subjected to long-term psychological treatment. More research is needed to 
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